Lithium for TBR1-related neurodevelopmental disorder
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This trial tests whether taking lithium for 2 years can improve symptoms in people with a TBR1 gene change that causes neurodevelopmental challenges. It aims to see if lithium is safe and helpful for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed change in the TBR1 gene.
- Age 6 years or older.
- A parent or guardian must be able to give consent and attend all visits.
- If female and able to have children, you must use highly effective birth control during the study and for 3 months after.
- If male and able to have children, you must use condoms or avoid sex during the study and for 5 days after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether lithium can help people with Cornelia de Lange syndrome (CdLS) who have a confirmed NIPBL gene mutation. It might improve their daily life and overall well-being.
This study looks at how to predict which people with hard-to-treat depression will benefit from adding lithium to their antidepressant. If you have treatment-resistant depression and are considering lithium, this trial may help find the best treatment for you.
This study looks at how lithium works in everyday life for people with bipolar disorder. It aims to learn about real-world treatment patterns and outcomes.
This study tests whether lithium can prevent memory loss or cognitive decline in older adults with mood disorders like depression or bipolar disorder. If you qualify, you would receive lithium treatment and be closely monitored.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This study uses MRI scans to look at how lithium affects the brain in people with bipolar disorder. It may help researchers understand why lithium works and how to use it better.
Hear when a new Proven Pathogenic or Probably Pathogenic TBR1 Variant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.